This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (77)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Congestive Heart Failure/ Cardiomyopathy  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

William B. Kannel, MD, MPH; Ralph B. D'Agostino, PhD; Halit Silbershatz, PhD; Albert J. Belanger, MS; Peter W. F. Wilson, MD; Daniel Levy, MD

Arch Intern Med. 1999;159:1197-1204.

Context  We devised a risk appraisal function to assess the hazard of heart failure in persons who are predisposed by coronary disease, hypertension, or valvular heart disease.

Objective  To provide general practitioners and internists with a cost-effective method to select people at high risk who are likely to have impaired left ventricular systolic function and may therefore require further evaluation and aggressive preventive measures.

Methods  The routinely measured risk factors used in constructing the heart failure profile include age, electrocardiographic left ventricular hypertrophy, cardiomegaly on chest x-ray film, heart rate, systolic blood pressure, vital capacity, diabetes mellitus, evidence of myocardial infarction, and valvular disease or hypertension. Based on 486 heart failure cases during 38 years of follow-up, 4-year probabilities of failure were computed using the pooled logistic regression model for each sex; a simple point score system was employed. A multivariate profile was also produced without the vital capacity or chest x-ray film because these may not be readily available in some clinical settings.

Results  Using the risk factors that make up the multivariate risk formulation—derived from ordinary office procedures—the probability of developing heart failure can be estimated and compared with the average risk for persons of the same age and sex. Using this risk profile, 60% of events in men and 73% in women occurred in subjects in the top quintile of multivariate risk.

Conclusions  Using this multivariate risk formulation, it is possible to identify high-risk candidates for heart failure who are likely to have a substantial yield of positive findings when tested for objective evidence of presymptomatic left ventricular dysfunction. The risk profile may also identify candidates who are at high risk for heart failure because of multiple, marginal risk factor abnormalities that might otherwise be overlooked.

From the Department of Preventive Medicine and Epidemiology, Evans Department of Clinical Research, Boston University School of Medicine, Boston, Mass (Drs Kannel, D'Agostino, Silbershatz, Wilson, and Levy and Mr Belanger); and the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Drs Wilson and Levy). These authors are affiliated with the Framingham Heart Study; see the acknowledgments at the end of this article for further information.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(11):1259-1260.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of Multiple Anthropometrics of Overweight and Obesity With Incident Heart Failure: The Atherosclerosis Risk in Communities Study
Loehr et al.
Circ Heart Fail 2009;2:18-24.
ABSTRACT | FULL TEXT  

Progressing From Risk Factors to Omics
Wilson
Circ Cardiovasc Genet 2008;1:141-146.
FULL TEXT  

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Ogawa et al.
JAMA 2008;300:2134-2141.
ABSTRACT | FULL TEXT  

Non-steroidal anti-inflammatory drugs and cardiac failure: meta-analyses of observational studies and randomised controlled trials
Scott et al.
Eur J Heart Fail 2008;10:1102-1107.
ABSTRACT | FULL TEXT  

Racial Disparities in Health Care Access and Cardiovascular Disease Indicators in Black and White Older Adults in the Health ABC Study
Rooks et al.
J Aging Health 2008;20:599-614.
ABSTRACT  

Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study
Gaede et al.
Diabetes Care 2008;31:1510-1515.
ABSTRACT | FULL TEXT  

Incident Heart Failure Prediction in the Elderly: The Health ABC Heart Failure Score
Butler et al.
Circ Heart Fail 2008;1:125-133.
ABSTRACT | FULL TEXT  

Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Schocken et al.
Circulation 2008;117:2544-2565.
ABSTRACT | FULL TEXT  

Profile-specific survival estimates: Making reports of clinical trials more patient-relevant
Julien and Hanley
Clin Trials 2008;5:107-115.
ABSTRACT  

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D'Agostino et al.
Circulation 2008;117:743-753.
ABSTRACT | FULL TEXT  

Antecedent Blood Pressure, Body Mass Index, and the Risk of Incident Heart Failure in Later Life
Lee et al.
Hypertension 2007;50:869-876.
ABSTRACT | FULL TEXT  

Congestive heart failure is a rare event in patients receiving imatinib therapy
Atallah et al.
Blood 2007;110:1233-1237.
ABSTRACT | FULL TEXT  

Association of parental heart failure with risk of heart failure in offspring.
Lee et al.
NEJM 2006;355:138-147.
ABSTRACT | FULL TEXT  

Stage B Heart Failure: Management of Asymptomatic Left Ventricular Systolic Dysfunction
Goldberg and Jessup
Circulation 2006;113:2851-2860.
FULL TEXT  

Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Davis et al.
Circulation 2006;113:2201-2210.
ABSTRACT | FULL TEXT  

Predictors of the onset of depressive symptoms in patients with heart failure
Havranek et al.
J Am Coll Cardiol 2004;44:2333-2338.
ABSTRACT | FULL TEXT  

Relations of Plasma Matrix Metalloproteinase-9 to Clinical Cardiovascular Risk Factors and Echocardiographic Left Ventricular Measures: The Framingham Heart Study
Sundstrom et al.
Circulation 2004;109:2850-2856.
ABSTRACT | FULL TEXT  

Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang et al.
NEJM 2004;350:655-663.
ABSTRACT | FULL TEXT  

Using Bayes' nomogram to help interpret odds ratios
Page and Attia
Evid. Based Med. 2003;8:132-134.
FULL TEXT  

Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study
Lloyd-Jones et al.
Circulation 2002;106:3068-3072.
ABSTRACT | FULL TEXT  

Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial
Davis et al.
ANN INTERN MED 2002;137:313-320.
ABSTRACT | FULL TEXT  

Obesity and the Risk of Heart Failure
Kenchaiah et al.
NEJM 2002;347:305-313.
ABSTRACT | FULL TEXT  

Antecedent hypertension and heart failure after myocardial infarction
Richards et al.
J Am Coll Cardiol 2002;39:1182-1188.
ABSTRACT | FULL TEXT  

Evidence based management of hypertension: Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review
Padwal et al.
BMJ 2001;322:977-980.
FULL TEXT  

Risk Factors for Congestive Heart Failure in US Men and Women: NHANES I Epidemiologic Follow-up Study
He et al.
Arch Intern Med 2001;161:996-1002.
ABSTRACT | FULL TEXT